Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis
- Resource Type
- Article
- Source
- In
The Lancet Public Health December 2016 1(2):e66-e75 - Subject
Primary Research Articles - Language
- ISSN
- 2468-2667